1205 related articles for article (PubMed ID: 34744510)
21. Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Glioblastoma Multiforme Patients Undergoing Postneurosurgical Radiotherapy Plus Concurrent and Adjuvant Temozolomide.
Topkan E; Besen AA; Ozdemir Y; Kucuk A; Mertsoylu H; Pehlivan B; Selek U
Mediators Inflamm; 2020; 2020():4392189. PubMed ID: 32565725
[TBL] [Abstract][Full Text] [Related]
22. The predictive value of a preoperative systemic immune-inflammation index and prognostic nutritional index in patients with esophageal squamous cell carcinoma.
Zhang H; Shang X; Ren P; Gong L; Ahmed A; Ma Z; Ma R; Wu X; Xiao X; Jiang H; Tang P; Yu Z
J Cell Physiol; 2019 Feb; 234(2):1794-1802. PubMed ID: 30070689
[TBL] [Abstract][Full Text] [Related]
23. Systemic Immune-inflammation Index is the Best Prognostic Factor in Patients with Advanced Stage Adenocarcinoma of the Lung Treated with Pemetrexed.
Bilgetekin I; Basal FB
J Coll Physicians Surg Pak; 2020 Sep; 30(9):933-939. PubMed ID: 33036677
[TBL] [Abstract][Full Text] [Related]
24. Preoperative systemic immune-inflammation index predicts prognosis and guides clinical treatment in patients with non-small cell lung cancer.
Yan X; Li G
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32175568
[TBL] [Abstract][Full Text] [Related]
25. Preoperative increased systemic immune-inflammation index predicts poor prognosis in patients with operable non-small cell lung cancer.
Gao Y; Zhang H; Li Y; Wang D; Ma Y; Chen Q
Clin Chim Acta; 2018 Sep; 484():272-277. PubMed ID: 29860033
[TBL] [Abstract][Full Text] [Related]
26. The prognostic values of systemic immune-inflammation index and derived neutrophil-lymphocyte ratio in EGFR-mutant advanced non-small cell lung cancer.
Yucel S; Bilgin B
J Oncol Pharm Pract; 2021 Jan; 27(1):71-77. PubMed ID: 32248739
[TBL] [Abstract][Full Text] [Related]
27. Effect of systemic inflammation biomarkers on overall survival after lung cancer radiotherapy: a single-center large-cohort study.
Abravan A; Salem A; Price G; Faivre-Finn C; van Herk M
Acta Oncol; 2022 Feb; 61(2):163-171. PubMed ID: 34979860
[TBL] [Abstract][Full Text] [Related]
28. [The prognostic value of preoperative peripheral blood inflammatory biomarkers for intrahepatic cholangiocarcinoma after radical resection].
Li Q; Zhang R; Fu JL; Zhang J; Su JB; Jin ZC; Chen C; Zhang D; Geng ZM
Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1194-1201. PubMed ID: 36380668
[No Abstract] [Full Text] [Related]
29. Systemic Immune-Inflammation Index (SII) is Useful to Predict Survival Outcomes in Patients After Liver Transplantation for Hepatocellular Carcinoma within Hangzhou Criteria.
Fu H; Zheng J; Cai J; Zeng K; Yao J; Chen L; Li H; Zhang J; Zhang Y; Zhao H; Yang Y
Cell Physiol Biochem; 2018; 47(1):293-301. PubMed ID: 29768257
[TBL] [Abstract][Full Text] [Related]
30. High Systemic Immune-Inflammation Index (SII) Represents an Unfavorable Prognostic Factor for Small Cell Lung Cancer Treated with Etoposide and Platinum-Based Chemotherapy.
Wang C; Jin S; Xu S; Cao S
Lung; 2020 Apr; 198(2):405-414. PubMed ID: 32016563
[TBL] [Abstract][Full Text] [Related]
31. Prognostic role of the systemic immune-inflammation index in brain metastases from lung adenocarcinoma with different EGFR mutations.
Li H; Wang G; Zhang H; Song X; Cao J; Zhang X; Xue R; Wang W; Jia S; Li Z
Genes Immun; 2019 Jul; 20(6):455-461. PubMed ID: 30410015
[TBL] [Abstract][Full Text] [Related]
32. Using the Systemic Immune-Inflammation Index (SII) as a Mid-Treatment Marker for Survival among Patients with Stage-III Locally Advanced Non-Small Cell Lung Cancer (NSCLC).
Biswas T; Kang KH; Gawdi R; Bajor D; Machtay M; Jindal C; Efird JT
Int J Environ Res Public Health; 2020 Oct; 17(21):. PubMed ID: 33143164
[TBL] [Abstract][Full Text] [Related]
33. Pre-treatment systemic inflammation response index and systemic immune inflammation in patients with primary central nerve system lymphoma as a useful prognostic indicator.
Matsuda R; Maeoka R; Morimoto T; Nakazawa T; Morisaki Y; Yokoyama S; Kotsugi M; Takeshima Y; Yamada S; Nishimura F; Park YS; Nakagawa I
J Neurooncol; 2024 Jul; 168(3):487-494. PubMed ID: 38658464
[TBL] [Abstract][Full Text] [Related]
34. [A Prognostic Model of Elderly Patients with Non-small Cell Lung Cancer
Based on Geriatric Nutritional Risk Index].
Zhang X; Xiong Y; Xu A
Zhongguo Fei Ai Za Zhi; 2023 Jul; 26(7):497-506. PubMed ID: 37653013
[TBL] [Abstract][Full Text] [Related]
35. High Neutrophil-To-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammation Index (SII) Are Markers of Longer Survival After Metastasectomy of Patients With Liver-Only Metastasis of Rectal Cancer.
Polk N; Budai B; Hitre E; Patócs A; Mersich T
Pathol Oncol Res; 2022; 28():1610315. PubMed ID: 35570841
[No Abstract] [Full Text] [Related]
36. Systemic Immune-Inflammatory Index, Tumor-Infiltrating Lymphocytes, and Clinical Outcomes in Esophageal Squamous Cell Carcinoma Receiving Concurrent Chemoradiotherapy.
Yang J; Zheng J; Qiu J; Zhang M; Liu L; Wang Z; Zheng Q; Liu Y; Chen M; Li J
J Immunol Res; 2023; 2023():4275998. PubMed ID: 37228442
[TBL] [Abstract][Full Text] [Related]
37. The prognostic value of inflammation markers in postoperative gliomas with or without adjuvant treatments.
Luo Y; Deng R; Zhong Q; Luo D; Li X; Chen X; Tao S; Feng Z; Jiayi L; Huang Y; Li J; Liu W
Medicine (Baltimore); 2021 Jun; 100(25):e26437. PubMed ID: 34160435
[TBL] [Abstract][Full Text] [Related]
38. The preoperative systemic immune-inflammation index is associated with an unfavorable prognosis for patients undergoing curative resection of esophageal squamous cell carcinoma after neoadjuvant therapy.
Obata Y; Kanda M; Shimizu D; Takami H; Inokawa Y; Hattori N; Hayashi M; Tanaka C; Nakayama G; Kodera Y
Surg Today; 2023 Aug; 53(8):964-972. PubMed ID: 36797438
[TBL] [Abstract][Full Text] [Related]
39. [Prognostic value of pretreatment neutrophil-to-lymphocyte ratio (NLR) in locally advanced non-small cell lung cancer patients treated with thoracic radiation].
Dong X; Zhou ZM; Bi N; Wang JB; Ran JT; Hui ZG; Liang J; Feng QF; Chen DF; Xiao ZF; Lyu JM; Wang XZ; Wang X; Zhang T; Deng L; Wang WQ; Wang LH
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):446-451. PubMed ID: 29936771
[No Abstract] [Full Text] [Related]
40. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
Deng M; Ma X; Liang X; Zhu C; Wang M
Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
